1746P Impact of PD-1/PD-L1 blockade therapy in COVID-19 infected cancer patients (pts) hospitalization: Results of an Italian study in the province of Modena and Reggio Emilia duri...

por Damato, A., Spallanzani, A., Berselli, A., Rovesti, G., Benatti, S., Luppi, G., Pinto, C.
Publicado 2020

Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy

por Bengala, C, Bettelli, S, Bertolini, F, Sartori, G, Fontana, A, Malavasi, N, Depenni, R, Zironi, S, Del Giovane, C, Luppi, G, Conte, P F
Publicado 2010

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

por Bengala, C, Bertolini, F, Malavasi, N, Boni, C, Aitini, E, Dealis, C, Zironi, S, Depenni, R, Fontana, A, Del Giovane, C, Luppi, G, Conte, P
Publicado 2010

FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer

por Bertolini, F, Malavasi, N, Scarabelli, L, Fiocchi, F, Bagni, B, Giovane, C Del, Colucci, G, Gerunda, G E, Depenni, R, Zironi, S, Fontana, A, Pettorelli, E, Luppi, G, Conte, P F
Publicado 2011

Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer

por Reni, M, Pasetto, L, Aprile, G, Cordio, S, Bonetto, E, Dell'oro, S, Passoni, P, Piemonti, L, Fugazza, C, Luppi, G, Milandri, C, Nicoletti, R, Zerbi, A, Balzano, G, Di Carlo, V, Brandes, A A
Publicado 2006